PGEN
NASDAQ · Biotechnology
Precigen Inc
$7.72
+0.02 (+0.26%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+840.0% upside
Low Target
$43.64
Average Target
$72.57
High Target
$99.14
Current Price
$7.72
Current
$7.72
$7.72
Target
$72.57
$72.57
$43.64
$72.57 avg
$99.14
Scenario Analysis
Bear Case
$43.64
465.3%
Low target
Base Case
$72.57
+840.0%
Avg target
Bull Case
$99.14
+1,184.2%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.95
-2.8% from high
52-Week Low
$2.99
+158.2% from low
50-Day SMA
$5.25
+47.0% vs SMA
RSI (14)
75.9
Overbought
Target vs 52W High
$72.57
+813.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |